New life science fund, Mirae Asset Capital Life Science, has launched with $50 million targeted towards U.S. biotechnology companies. The fund, which is part of the Mirae Asset Financial Group, aims to support private biotechs from seed funding to series C. Mirae Asset Capital Life Science is interested in areas such as oncology, immunology, cardiovascular and metabolic diseases, CNS and ophthalmology, and genetic diseases. The fund is also open to using AI and machine learning tools for drug discovery and protein engineering. In addition to its launch, the firm has already led a $75 million series C round for an unnamed oncology company that is developing small molecule precision therapies.
Power Moves: Asian Financial Group Launches $50M US Biotech Fund
Latest from Blog
Venture Capital Boom: AI Startups Revolutionizing Healthcare Funding
TLDR: Healthcare AI startups have raised about $60 billion in venture capital funding over the past decade. Only over 5% of companies selling to health systems have matured beyond seed and early-stage
Decrease in Private Market Funding in Second Quarter
TLDR: Bloomberg article addresses the issue of unusual activity detection in computer networks. Readers are prompted to confirm they are not robots by clicking a box. Bloomberg recently published an article discussing
Impact Founder’s $250M Raise: VC Insight and Outlook
TLDR: Key Points: Bloomberg article addressing unusual activity detection on computer networks prompting users to verify they are not robots. Inquiries related to the message can be directed to the support team
Top 10 Biotech and AI Funding Rounds of the Week
TLDR: Big week for biotech and AI funding rounds Top 10 funding rounds highlighted The past week saw significant funding rounds in the biotech and AI sectors, with two notable nine-figure rounds
AI Startup World Labs Secures $230M Funding from Top Investors
TLDR: – AI startup World Labs launched with over $230 million in total funding led by Andreessen Horowitz, NEA, and Radical Ventures. – Co-founded by Fei-Fei Li, World Labs aims to enhance